Zevra Therapeutics Inc Stock (ZVRA) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 4.81%37.76 | 39.66 | 36.22 | 34.13 | 26.06 |
15.53%19.13 | 16.56 | 20.78 | - | - | |
| Selling, General, and Administrative | 15.53%19.13 | 16.56 | 20.78 | - | - |
| Costs And Expenses | 14.36%24.07 | 21.05 | 25.18 | 22.97 | 20.37 |
| Operating Income/Loss | 30.98%11.58 | 16.78 | 52.15 | 9.32 | 4.14 |
| Nonoperating Income/Loss | 304.32%8.14 | -3.98 | -7.34 | 3.35 | -5.12 |
| Income/Loss From Continuing Operations Before Tax | 54.12%19.72 | 12.79 | 44.80 | 12.67 | -0.98 |
| Income Tax Expense/Benefit | 87.38%0.51 | 4.04 | 6.91 | 0.50 | -0.43 |
119.47%19.21 | 8.75 | 37.89 | 12.17 | -0.54 | |
| Attributable To Parent | 119.47%19.21 | 8.75 | 37.89 | 12.17 | -0.54 |
| Available To Common Stockholders, Basic | 119.52%18.42 | 8.39 | 36.32 | 11.83 | -0.54 |
| Preferred Stock Dividends And Other Adjustments | - | - | - | 0.34 | - |
| Basic Average Shares | 0.43%59.41 | 59.16 | 58.41 | 0.36 | 55.95 |
| Diluted Average Shares | 0.65%61.73 | 61.34 | 60.23 | 0.48 | 55.95 |
| Basic Earnings Per Share | 121.43%0.31 | 0.14 | 0.62 | 0.20 | -0.01 |
| Diluted Earnings Per Share | 85.71%0.26 | 0.14 | 0.60 | 0.19 | -0.01 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | 118.38%0.78 | 0.36 | 1.57 | 0.34 | - |